Wedbush Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $58

Wedbush analyst Robert Driscoll maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and raises the price target from $52 to $58.